Hjem › Bløddelssarkom › Texas › Houston
Bløddelssarkom kliniske forsøg i Houston, TX
32 studier for Bløddelssarkom søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- UT MD Anderson Cancer Center, Houston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
RekruttererFase 1/2
- UT MD Anderson Cancer Center, Houston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RekruttererFase 1/2
- Baylor College of Medicine, Houston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
RekruttererFase 1
- The University of Texas MD Anderson Cancer Center, Houston
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- The University of Texas MD Anderson Cancer Center, Houston
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
RekruttererFase 1/2
- University Of Texas MD Anderson Cancer Center, Houston
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
RekruttererFase 1
- UT MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RekruttererFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
RekruttererFase 1
- UT MD Anderson Cancer Center, Houston
Actinium Therapy for Late-stage Aggressive Sarcomas
RekruttererFase 1
- MD Anderson Cancer Center, Houston
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
RekruttererObservationsstudie
- M D Anderson Cancer Center, Houston
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
RekruttererFase 2
- MD Anderson Cancer Center, Houston
T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
RekruttererFase 1
- MD Anderson Cancer Center, Houston
A Study of MGC026 in Participants With Advanced Solid Tumors
RekruttererFase 1
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
Rekrutterer
- M D Anderson Cancer Center, Houston
A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
RekruttererFase 1
- The University of Texas M. D. Anderson Cancer Center, Houston
IDOV-Immune for Advanced Solid Tumors
RekruttererFase 1
- MD Anderson Cancer Center, Houston
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
RekruttererObservationsstudie
- MD Anderson Cancer Center, Houston
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
RekruttererFase 2
- M D Anderson Cancer Center, Houston
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
RekruttererFase 1
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
RekruttererFase 2
- M.D. Anderson Children's Cancer Hospital, Houston
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
RekruttererFase 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Rekrutterer
- M D Anderson Cancer Center, Houston
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
RekruttererFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
RekruttererFase 1
- Texas Children's Hospital, Houston
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RekruttererFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
BostonGene and Exigent Genomic INsight Study
RekruttererObservationsstudie
- Oncology Consultants, Houston
Bløddelssarkom forsøg i andre byer
- New York City, NY19 studier
- Boston, MA18 studier
- St. Louis, MO14 studier
- Columbus, OH13 studier
- Los Angeles, CA13 studier
- Washington, DC12 studier
- Memphis, TN11 studier
- Philadelphia, PA10 studier
- Rochester, MN9 studier
- Nashville, TN9 studier
- Aurora, CO9 studier
- Queens, NY9 studier
Andre studier i Houston
- Ikke-småcellet lungecancer145 studier
- Brystkræft126 studier
- Kræft (alle typer)121 studier
- Metastatisk cancer104 studier
- Colorektal kræft102 studier
- Ægstockræft89 studier
- Akut myeloid leukæmi85 studier
- Lungecancer78 studier
- Prostatakræft76 studier
- Livmoderslimhindekræft68 studier
- Bugspytkirtelkræft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.